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We investigated the eﬀects of antioxidant activity of fermentation product (FP) of ﬁve Thai indigenous products on oxidative
stress in Wistar rats with streptozotocin (STZ)-induced diabetes type II. The rats were fed with placebo and with the FP (2 and
6mL/kg body weight/day) for 6 weeks. Rutin, pyrogallol and gallic acid were main compounds found in the FP. Plasma glucose
levels in diabetic rats receiving the higher dose of the FP increased less when compared to the diabetic control group as well as the
groupreceiving thelowerFP dose(13.1%,29%,and21.1%),respectively. Asigniﬁcantdose-dependent decrease inplasmalevelsof
thiobarbituricacidreactive substance(P<. 05)wasobserved. Inaddition,thedosesof2and6mLFP/kg/daydecreased thelevelsof
erythrocyte ROS in diabetic rats during the experiment, but no diﬀerence was observed when compared to the untreated diabetic
rat group. Results imply that FP decreased the diabetes-associated oxidative stress to a large extent through the inhibition of lipid
peroxidation. The FP also improved the abnormal glucose metabolism slightly but the diﬀerence was not statistically signiﬁcant.
Thus, FP may be a potential therapeutic agent by reducing injury caused by oxidative stress associated with diabetes.
1.Introduction
Diabetic mellitus (DM) comprises a group of common
metabolic disorders that share the phenotype of hyper-
glycemia which aﬀects the metabolism of carbohydrates,
lipids and proteins. Prolonged periods of hyperglycemia
lead to glucose degradation within living tissues, causing
accumulation of glucose within organ cells, which can result
in complications of DM such as coronary heart disease,
retinopathy,nephropathies,andneuropathies[1–3].In2007,
the International Diabetes Federation reported that the
worldwide prevalence of DM has risen dramatically. It is
estimated that by 2025 the prevalence of DM worldwide will
rise from 246 million to 380 million people. The etiology
and pathophysiologyof have been a topicof much interest in
recent years especially the relationship between free radicals
produced by the metabolism of proteins, DNA, and lipids
in living organisms and the increase in oxidative reactions
which result in molecular and tissue damage in the body.
The cellular toxicity caused by overproduction of free
radicals is called oxidative stress. Therefore, free radical pro-
duction resulting in oxidative stress is a popular theory that
explains the etiology and pathophysiology of the biological
eﬀects of DM, especially in regard to cell damage, cellular
degeneration, and subsequent complications. Reports both
in vitro and in vivo have demonstrated that hyperglycemia
causes an increase offree radical in cells, which leadsto acute
toxicity and molecular destruction, aﬀecting the cellular
mediators. These conditions lead to insulin resistance, beta
cell dysfunction, and impaired insulin secretion result-
ing in the complications of type II DM. In the literatures,
antioxidants enable to decrease or inhibit oxidation can be2 Evidence-Based Complementary and Alternative Medicine
found naturally or synthesized from fermentation of Rhus
hirta, Quercus alba, and Cornus stolonifera [1, 4–7]. Natural
antioxidants such as polyphenolic compounds and their
eﬀects against free-radical scavenging and oxidative stress
have been studied [8–12]. Biologically fermented plant
products appear as a clear brown liquid with a sour taste due
tothefermentation ofplants, herbs, vegetables,or fruits with
sugar in a closed environment with lactic producing bacteria
or probiotic bacteria. A previous study indicated that they
are rich in antioxidants with antioxidative activity similar to
butylated hydroxyanisole and green tea [13]. Furthermore,
studies indicate that the antioxidative activity increased
upon fermentation, which dissolves the ingredients and
bacteria to release useful chemicals and phytochemicals in
the process. During Lactobacillus fermentation organic acids
are formed and accumulated, possibly leading to protein
hydrolysis and solubilisation of antioxidant ferulic acid from
cell wall plant materials [14–16]. Fermentation of grain food
withAspergillus oryzae possesses strong antioxidant and free-
radicals scavenging activities [17]. Antioxidative and anti-
inﬂammatory activities of the biologically fermented plant
productscan be utilized alternatively for improving health as
well as treatment for patients with such diseases as HIV and
cancer [18].
Biologically fermented plants locally made in Thailand
and other countries are consumed to improve health. In
2004, a report was presented in a meeting on standards
and safety of biologically fermented plant products for
consumptionhostedbytheNationalScienceand Technology
DevelopmentAgency in Thailand. The report stated random
interviews of 235 biologically fermented plant product con-
sumers nationwide who 10.2 percent drank the product
to treat diabetic mellitus (DM). Nevertheless, very little
scientiﬁc evidence on the impact of health in vitro and
vivo on diabetic patients exist. Thus, this study aimed to
assess the eﬀect of selected Thai biologically fermented
plant products on oxidative stress in streptozotocin- (STZ-)
induced diabetes type II Wistar rats. Levels of oxidative
stress makers including plasma TBARS, superoxide anion
(O2
•−) and nitric oxide (NO), and erythrocyte radicals were
measured.
2.Materialsand Methods
2.1. Chemicals and Plant Product. Streptozotocin (STZ),
malondialdehyde (MDA), 2,2 -azino-bis(3-ethylbenzthia-
zoline-6-sulphonicacid)(ABTS),1,1 ,3,3 -tetramethoxypro-
pane, thiobarbituric acid (TBA), Folin-Ciocalteu’s reagent,
rutin, gallic acid, pyrogallol, catechin, and caﬀeic acid
were purchased from Sigma-Aldrich Chemical Company
(St. Louis, MO, USA). 2 ,7 -Dichloroﬂuorescein diac-
etate (DCFH-DA) was obtained from Molecular Probes
(Eugene, OR, USA). β-Nicotinamide adenine dinucleotide,
reduced disodium salt (NADH),2H-(tetrazolium,3,3 -(3,3 -
dimethoxy (1,1 -biphenyl)-4,4 -diyl) bis(4-nitrophenyl)-5-
(phenyl)dichlorideornitrobluetetrazoliumchloride(NBT),
ethylenediaminetetraacetic acid (EDTA) disodium salt, and
phenazine methosulphate (PMS) were purchased from
Fluka Chemicals(BuchsSwitzerland). Ultrapure grade water
(Milli-Q water) was from Millipore Corporate (Billerica,
MA, USA). Ethyl acetate (AR grade) and methanol
(HPLC grade) were purchased from Mallinckrodt Company
(Mallinckrodt J.T. Baker, Inc. Phillipburg, NJ, USA). Other
chemicals were analytical reagent or the highest pure grade.
2.2. Preparation of Starter Culture Inoculum. Lactic acid pro-
ducing bacteria (Lactobacillus casei) was used as starter cul-
ture and identiﬁed by using biochemical tests and API 50CH
carbohydrate fermentation strip test (bioM´ erieux SA Inc.,
Marcy l Etoile, France). Preculture plates of the isolate were
prepared by streaking a loopful of stock starter culture on
Difco Lactobacilli MRS Agar plate (Difco, Detriot, MI USA)
and incubated at 37±1◦Ci n6 . 1 %C O 2 for 48 hours. Single
colony was then inoculated into Difco Lactobacilli MRS
Broth(Difco,Detriot, MIUSA)and incubated at37±1◦Cin
6.1%CO2 for10–15hours.Thebrothculture(approximately
109 CFU/mL) was transferred to the fermented medicinal
plant juice (FMPJ) (10%, v/v) and incubated at 37 ± 1◦Cf o r
18–25 hours.
2.3. Preparation of Fermentation Product. Fermentation
product of ﬁve Thai indigenous plants was prepared at
the Research and Development of Health Product Unit,
DepartmentofPharmaceuticalScience,FacultyofPharmacy,
Chiang Mai University, Thailand. The plants including
Malacea tree (Phyllanthus emblica Linn., PE), Indian mul-
berry (Morinda citrifolia Linn., MC), Heart leaf (Houttuynia
cordata Thunb., HR), Myrobalan (Terminalia chebula Retz.,
TC), and Krachai-Dam (Kaempferia parviﬂora Wall., KP)
were used in this study. In preparation, the plants were
cut into small pieces and crushed with the crusher. The
crushed plants (3.47kg each) were mixed with cane sugar
(1.16kg) and reverse osmosis water (11.57kg), then inocu-
lated with the starter culture (1.8kg) containing potassium
metabisulﬁte (250mg/l). The mixture was contained in an
air locked rubber polypropylene tank (18.9 liter capacity),
fermented separately in an incubation room at 30 ± 2◦Cf o r
1 month and ﬁltered. The fermentative juices of the PE, TC,
KP, MC, and HC (10:10:5:20:55, v/v/v/v/v) were mixed
together “called fermentation product (FP)” and used in the
experiments. The FP was further determined antioxidant
activity and identiﬁed phenolic compounds as described
below.
2.4. Preparation of Sample Solution. The isolation of pheno-
lics from the FP was performed by solid phase extraction
(SPE) [19]. Brieﬂy, the SPE column (C18 cartridge, 3-mL
capacity, 5% carbon load, Whatman, Maidstone, Kent, UK)
was washed with ethyl acetate (3mL), methanol (3mL)
and Milli Q water (5mL), respectively. The FP (1.0mL)
was loaded onto the column and washed three times with
deionized water. Compounds retained in the column were
elutedwith ethyl acetate (3.0mL). The eluatewas evaporated
at room temperature and the residue was reconstituted with
methanol (1.0mL). Solutions of reference standards such as
rutin, gallic acid, pyrogallol, catechin, and caﬀeic acid were
prepared in methanol. The solutions were ﬁltered through a
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2.5. Identiﬁcation of FP Components by HPLC and GC-MS
Techniques. The analytical Agilent 1100 Series HPLC sys-
tem (Agilent Technologies, Santa Clara, CA, USA) com-
prises quaternary high pressure pumps, thermoregulated
autosampler, photodiode-array detector, a modular HP
ChemStation Software installed in a computer system.
Mobile-phase solvent consisting of water/ 0.4% acetic
acid/methanol/acetronitrile (70:20:5:5, v/v/v/v) was ﬁl-
tered(0.45μm membrane, polysulphonetype)and ultrason-
ically degassed before use. Firstly, the column was calibrated
using standard rutin, pyrogallol, gallic acid, catechin, and
caﬀeic acid to determine their speciﬁc retention times (RT).
The sample and the reference standards (6μL) were applied
to the Hypersil column (ODS type, 250mm ×4mm id.,
5μm, Thermo Fisher Scientiﬁc Inc., Waltham, MA, USA)
temperature-controlled at 25◦C and eluted with the mobile
phase at a ﬂow rate of 0.7mL/min. Eluents were monitored
with the PDA detector at the wavelengths of 200, 280,
and 360nm. Data were recorded and analyzed with the
ChemStation Software.
Active ingredients of the FP were also analyzed by
using a GC-MS technique at the Science and Technology
Service Center, Chiang Mai University, Thailand. A gas
chromatography machine (Agilent Technologies, Inc., Santa
Clara, CA, USA) used advanced electronic pneumatics
control (EPC) and extremely accurate temperature control.
The system was included a column (HP-5MS Agilent, 5%-
phenyl-methylpolysiloxane, 30m × 0.25mm i.d., 0.25μm
ﬁlm thick) and conditioned with inlet of 270◦C, 1.0-μL
split ratio (10:1), oven temperature of 50◦C( 1 2 ◦C/min) →
260◦C (42.5min), a ﬂow rat of helium gas carrier at
1.0min/min.Amassspectrometer(Agilent5975SeriesMSD,
Triple-Axis HED-EM detector programmable temperature
up to 350◦C) was online connected to the GC machine. Data
of analysis were acquired using ChemStation program. Mass
spectra of analyzed samples were compared with those of
standard compounds as stored in a database library.
2.6. ABTS Radical Decolorizing Assay. The method used
is based on the ability of antioxidative compounds to
quench the ABTS radical cation (ABTS•+), a blue-green
chromophore with characteristic absorption at 734nm,
compared with the ascorbic acid, a water-soluble vitamin
C analog [20, 21]. A stable stock solution of ABTS•+ was
produced by reacting aqueous solution of ABTS (7mM)
with potassium persulfate solution (a ﬁnal concentration of
2.45mM) and allowed the mixture to stand in a dark at
room temperature for 12–16 hours before use. The solution
was diluted with ethanol to obtain an absorbance of 0.70
± 0.02unit at 734nm. The FP was dissolved in ethanol.
An aliquot of each sample (20μL) in ethanolic solution was
added into 2.0mL of ABTS•+ solution, the absorbance was
monitored for 3min at 734nm, veriﬁed by a UV/VIS spec-
trophometer (Jasco model 7800). The antioxidant activity
was expressed as mg ascorbic acid equivalents (mg AE/mL
of FP).
2.7. Quantiﬁcation of Phenolics Content. Content of total
phenolics in the FP was determined by Folin-Ciocalteu
reagent [22].AdiluteextractoftheFP(0.5mLof1:10g/mL)
orgallic acid(standard phenoliccompound)was mixed with
Folin-Ciocalteu reagent (5mL, 1:10 diluted with distilled
water) and aqueous Na2CO3 ( 4m L ,1M ) .T h em i x t u r e sw e r e
allowed to stand for 15min and the total phenolics content
was determined by colorimetry at 765nm. The standard
curve was prepared using gallic acid in methanol/water
(50:50, v/v) and expressed as gallic acid equivalents (mg
GAE/mL of FP).
2.8. Analysis of Flavonoids Content. The ﬂavonoids content
was determined by the aluminum chloride colorimetric
method [23] .T h eF Ps a m p l e( 0 . 5 m Lo f1 : 1 0 g / m Li n
methanol was separately mixed with 1.5mL of methanol,
0.1mL of 10% aluminum chloride, 0.1mL of 1M potassium
acetate and 2.8mL of distilled water. It remained at room
temperature for 30min; the absorbance was measured at
415nm. The standard curve was prepared by preparing var-
ious concentrations of quercetin in methanol and expressed
as quercetin equivalents (mg QE/mL of FP). Quercetin is the
major ﬂavonoids occurring ubiquitously in foods of plant
origin and has been frequently used as a model compound
showing the antioxidant property [24].
2.9. Determination of Hydrolysable Tannins Content. Pheno-
lics are secondary plant metabolites, which tannins is the
group of the phenolics and potential biological antioxidant.
Folin-Denis assay is the most widely used method for quan-
tiﬁcation of total phenolics in plant materials and beverages.
Content of hydrolysable tannins (such as gallotannins and
ellagitannins) in the FP was determined by a modiﬁed
method of [25]. The FP sample (0.1mL) was mixed with
0.5mL Folin-Denis reagent followed by 1mL of Na2CO3
(0.5%) solution and distilled water (up to 5mL). The optical
density (OD) was measured at 775nm within 30min of the
reaction against the reagent blank. Results were expressed as
mg GAE/mL of FP.
2.10. Animal Study. Male Wistar rats (180–200g) were
purchased from the National Animal Laboratory Center,
Mahidol University at Salaya Campus, Bangkok, Thailand.
Theratswerehousedinstainless-steel cages,withconstantly-
controlledroomtemperature(23±2◦C),humiditytempera-
ture (65 ± 10%), and 12/12h light/dark cycle. They were fed
a standard chow diet containing 12% moisture, 24% crude
protein, 4.5% fat, 5% ﬁber, 3040kcal/kg metabolic energy,
1% Ca, 0.9% P, 0.2% Na, 1.17% K, 0.23% Mg, 171ppmMn,
22ppmCu, 100ppmZn, 180ppmFe, 1.82ppmCo, 0.1% Se,
20000IU/kg vitamin A, 4000IU/kg vitamin D, 100mg/kg
vitamin E, 5mg/kg vitamin K, 20mg/kg vitamin B1,
20mg/kg vitamin B2, 20mg/kg vitamin B6, 20mg/kg vita-
min B12, 100mg/kg niacin, 6mg/kg folic acid, 0.4mg/kg
biotin, and 1500mg/kg choline chloride. Sterile deionized
water was ﬁlled in a clean glass bottle and given ad libitum.
All procedures were approved by the Ethics Committee for
the use of experimental animals in the Faculty of Medicine,
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2.11. Experimental Design. All rats were acclimatized for
ao n e - w e e kp e r i o d ,t h e nw e i g h t - m a t c h e di n t on o r m a la n d
diabetes type II control groups. A single dose of STZ
45mg/kg body weight (BW) was injected intraperitoneally
(IP) to induce diabetes in one [26] and the other received
vehicle only. One week after the STZ treatment, blood
samples were taken from tail vein and plasma glucose levels
were measured. Rats with fasting plasma glucose levels above
250mg/dL were regarded as having diabetes. The rats were
randomlydividedintofourgroupsandFPwasadministrated
to the experiment group by oral gavage feeding once a day as
follows.
Group 1: normal control rats (n = 9) given vehicle
only.
Group 2: the diabetic control rats (n = 13) given ve-
hicle only.
Group 3: the diabetic rats (n = 11) treated with FP at
ad o s eo f2m L / k gB W .
Group 4: the diabetic rats (n = 12) treated with FP at
ad o s eo f6m L / k gB W .
Their fasting (8–12hrs) bloods were collected every 2
weeks for analysis. The rats were treated for 6 weeks and
sacriﬁced.
2.12. Measurement of Plasma Glucose Concentration. The
blood was collected in a sodium ﬂuoride/oxalate tube and
spun in a refrigerated centrifuge (Hettich MIKRO 22R,
Andreas Hettich GmbH & Co. KG, Tuttlingen, Germany)
with a 35◦ angle rotor at 3500rpm (1123g), 4◦Cf o r
15min. Plasma glucose concentration was determined with
glucose oxidase/peroxidase method [27] using a commercial
assay kit supplied by BIOTECHNICAL Company, Bangkok,
Thailand. The assay procedure was followed according to the
manufacturer instruction.
2.13. Determination of Plasma TBARS. TBARS method was
used to evaluate lipid peroxidation [28]a n ds l i g h t l ym o d i -
ﬁed. Brieﬂy, blood samples of healthy and diabetic rats were
collected in heparinized tube and spun in the refrigerated
Hettich centrifuge at 1123g, 4◦C for 15min. The plasma
was removed to measure for lipid peroxidation by TBARS
assay. Forty microlitres of 0.2% butylated hydroxytoluene
wereaddedintoplasmasample (0.375mL)andmixedgently.
The mixture was divided into three equal aliquots (one was
used as a sample blank, and the others were used as a
duplicate). After 750μL of phosphoric acid (0.44MH3PO4)
were added to each tube, 250μLo f0 . 6 %( w / v )T B Ar e a g e n t
were added to both assay tubes and 250μl of deionized water
were added to the blank tube. All mixtures were incubated
at 90◦C for 30min, cooled down at room temperature, and
the absorbance was read at 532nm against the reagent blank.
Data obtained from three independent experiments of the
duplicate were expressed as MDA equivalents (μM) using
1,1,3,3-tetramethoxypropane as a reference standard.
2.14.Fluorescent-Labeled FlowCytometryof ErythrocyteReac-
tive Oxygen Species. Red blood cells (RBC) oxidative stress
wasanalyzedbytheﬂowcytometry[29].Brieﬂy,wholeblood
(5μL) was diluted with phosphate buﬀered saline (PBS)
to reach 1 × 106 RBC/mL. Then, 20μLo f0 . 4m MD C F H -
DA (dissolved in methanol) were added and incubated for
15min at room temperature. The cell suspension (250μL)
was spun in the refrigerated Hettich centrifuge at 3502g,
10◦C for 10min and the excess dye was removed. The RBC
pellet was washed three times with PBS and resuspended in
500μL of PBS. The content of reactive oxygen species (ROS)
was measured with a ﬂow cytometer (BD FACSCalibur, BD
Biosciences, Mississauga, ON, Canada) using saline as the
sheath ﬂuid, which cell count was set at 10,000cells. The
ﬂuorescence intensity (FI) was measured at an excitation
wavelength of 350nm and an emission wavelength of
450nm. BD CellQuest v3.3 program software provided user-
deﬁned calculation, reagent and sample-speciﬁc gating, and
overlays.
2.15. Superoxide Anion (O2
•−) Scavenging Activity Assay.
Superoxide level was measured using a colorimetric method
[30]. The O2
•− scavenging activity was determined by
measuring the decrease in ratio of the reductionof NBT. The
plasma samples were added to the reaction buﬀer (50mM
PBS pH 7.4, 125μME D T A ,6 2μMN B T ,a n d9 8μMN A D H )
containing 33μMP M S .A f t e ri n c u b a t i o na t3 7 ◦Cf o r3 0m i n ,
the absorbance was measured at 560nm, as an index of NBT
reduction, using a 96-well microplate reader (Multimode
detector, Beckman Coulter, Inc., Fullerton, CA, USA).
2.16. Nitric Oxide Radical (NO
•) Inhibition Assay. Nitric
oxide radical inhibition was estimated via the nitrite and
nitrate levels following the method [31]. Brieﬂy, nitrate
in plasma was converted to nitrite by incubation with
nitrate reductase in PBS (pH 7.4). Nitrite and nitrate levels
were measured by a microplate assay method based on
the Griess diazotization reaction. Griess reagent (Promega
Corporation, Madison, MA, USA) contained 0.2% N-1-
naphthylenediamine dihydrochloride and 2% sulphanil-
amide in 5% phosphoric acid. A pink colored chromophore
is formed in diﬀuse light. The absorbance of these solutions
was measured at 520nm against the corresponding blank
solutions. Sodium nitrite was used as a standard.
2.17. Statistical Analysis. Data were expressed as means ±
standard error of means (SEM). They were analyzed by the
diﬀerence between groups by one-way analysis of variance
(ANOVA), using Dunnett’s test and those at P<. 05 were
considered to be statistically signiﬁcant.
3.Resultsand Discussion
3.1. HPLC/UV Absorption and GC/MS Analyses of Phenolic
Compounds. Our recent study has shown that the PE, TC,
MC,KP, andHCconstitutedphenolicacids(2535 ± 68,2275
± 436, 50 ± 8, 100 ± 8 and 295 ± 22mgGAE/g, resp.),
ﬂavonoids (50 ± 1, 99 ± 6, 68 ± 1, 104 ± 1 and 191 ±
2mgQE/g, resp.), and tannins (0.20 ± 0.01, 0.15 ± 0.01,
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equivalent (TAE)/g, resp.) [32]. In this study, one milliliter
o ft h eF Pw a sf o u n dt oh a v ed i ﬀerent levels of subclasses of
phenolic compounds as following: phenolics 27.3 ± 1.1mg
GAE, total ﬂavonoid 2.24 ± 0.02mg QE, and hydrolyzable
tannins 0.051 ± 0.002mg. It also had an antioxidant activity
index of 31.31mg GAE/mL of the FP (Table 1).
Bramati and colleagues applied the HPLC/UV method
to the quantitative characterization of major ﬂavonoids in
unfermented and fermented indigenous plants and found
rutin (1.69 ± 0.14mg/g) was one of major components [33].
ResultofHPLC/200-nm detectiondemonstrated appearance
of the rutin, gallic acid, pyrogallol, catechin, and caﬀeic
acid peaks 3.2, 5.5, 6.3, 22.7, and 30.4min, respectively,
(Figure 1). In HPLC proﬁle of the FP we found ﬁve main
compounds including rutin (RT = 3.21min), gallic acid
(5.56min), pyrogallol (6.34min), and two other phenolics
(RT = 15.96 and 27.98min); however, caﬀeic acid was
not detected. When amounts of these compounds were
estimated from the corresponding peak areas, they were
2.76% rutin, 5.58% gallic acid, 6.60% pyrogallol, 6.03% cat-
echin, 9.70% unidentiﬁed compound I (RT 15.96min), and
38.83% unidentiﬁed compound II (RT 27.98min). Gallic
acid and the unidentiﬁed compound II exhibited strong UV
absorption at 280nm (11.07 and 74.35% peak area, resp.).
The observation of 360nm absorbance compounds possibly
identiﬁed ﬂavonoids group present in the FP.
GC/MS method was used to proﬁle polyphenolic com-
pounds in microbial fermentation products [34]. Here,
GC/MSanalysisdemonstrates thegallic acidwas oneofthree
main components present in the FP (Figure 2). Pyrogallol
was measured as a metabolite of gallotannin whereas gallic
acid was formed by hydrolysis of the gallotannins or tannic
acid. Tannins are unfeasible for GC analysis due to their
large molecular weight, polarity and thermal instability.
Nonetheless,pyrolysis-GC/MS canrapidlyanalyzethedegra-
dation products and characterize the original samples. With
the chromatographic analysis fermentation of ﬁve Thai
indigenous plants possibly produced large amounts of gallic
acid, pyrogallol, catechin, and small amount of condensed
(polymeric) tannins.
3.2. Eﬀect of FP on Body Weight. Result in Figure 3 shows
the eﬀects of FP on the changes in body weight of rats after
the 6 week experimental period. The average body weight
of the diabetic control group was initially 170.4 ± 3.0g and
progressively increased to 313.5 ± 12.5g (increase 37.7%) by
the 6th week. The weight gain in the normal control group
during the experimental period was 47.6%. The increase in
body weight of all diabetic groups was signiﬁcantly lower
than the normal rats (P<. 05) at week 0 and at the 2nd–6th
week (P<. 001). The FP-treated groups had slightly higher
weight gain (42.7% and 41.6%) than diabetic rats untreated
(37.7%) until the 6th week, but that was not statistically
signiﬁcant.
Hyperphagia and increased water intake also accompa-
nied polyuria and glucosuria in the diabetic groups (data
not shown). An elevated food intake in the diabetic rats
probably would be an adaptive behavior in response to the
Table 1: Contents of main phenolics and total antioxidant activity
in the fermentation product (FP).
Measurement Amounts
Phenolics (mg GAE/mL) 27.3 ± 1.1
Flavonoids (mg QE/mL) 2.24 ± 0.02
Hydrolyzable tannins (mg GAE/mL) 0.051 ± 0.002
Antioxidant activity (mg AE/mL) 31.31 ± 0.04
Abbreviations: GAE: gallic acid equivalents, QE: quercetin equivalents, AE:
ascorbic acid equivalents. Values expressed as means ± SD (n = 5).
loss of calories and cellular starvation. In response to cellular
hunger for glucose in diabetes, lipolysis and proteolysis were
enhanced [35]. Type 2 diabetes is caused not only by a defect
in β-cell function and insulin resistance butalso by the α-cell
dysfunction withrelative glucagonhypersecretion. Glucagon
inhibits glucose-utilization pathways and the storage of
metabolic fuels and also activates hepatic gluconeogenesis,
glycogenolysisandlipolysis[36].Thediabeticratshadhyper-
phagia related to a marked hyperglycemia; consequently,
glucosuria occurred along with polydypsia and osmotic
diuresis in the diabetic rats. As a result of dehydration, the
diabetic rats had to drink a lot of water (polydypsia) [37].
Previousstudiesindicated thatgallic acidand rutinexhibited
antihyperglycemic and antioxidative activity in STZ-induced
rats [38] and had hypolipidemic eﬀect on mice fed high fat
diet [39, 40].
3.3. Eﬀect of FP on Plasma Glucose Levels. As shown in
Figure 4, the level of plasma glucose was signiﬁcantly
increased (P < .05) in the rats with STZ-induced diabetes
(29% from 276.6mg/dL to 356.7mg/dL) during the entire
experimental period when compared with the normal rats
group (6.4% from 143.1mg/dL to 152.2mg/dL). However,
the administration of a dose of 6mL/kg/day FP reduced the
progressive increase of plasma glucose levels during weeks
1–6 (increased only 13.1%) when compared to the diabetic
control group (29%) and the low-dose group (21.1%) but
not signiﬁcantly.
Fermented fruit and plant beverages were used to
improve health as well as an alternative therapy because
they had anti-inﬂammatory and antioxidative activities [13,
18, 41]. The FP used in this study was composed of ﬁve
Thai indigenous plants, rich in phenolic compounds and
antioxidant activities (Table 1). The therapeutic role of FP
is shown to be attributed to the improvement of diabetic
oxidative stress; therefore, it may be a potential therapy for
diabetes and its complications.
The administration of FP reduced the physiological
changes associated with diabetes, implying that FP normal-
ized energy utilization and metabolism. Oxidative stress in
diabetes plays a key role in vascular pathogenesis and is an
earlymarkerindevelopmentofendothelialdysfunction [42].
We found that the administration of a dose of 6mL/kg/day
of FP tended to reduce the physiological changes associ-
ated with diabetes via delaying or reducing the increase
of plasma glucose level in diabetic rats better than the6 Evidence-Based Complementary and Alternative Medicine
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Figure1:HPLC/UVabsorptionanalysisoftheFP.EluentsoftheFPwerecomparedwiththephenolicstandards:rutin,gallicacid,pyrogallol,
catechin, and caﬀeic acid as previously mentioned in the Method Section.
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diabetic untreated group. This implies that high doses of FP
normalized energy utilization and metabolism and possibly
suppressed glucose production through the gluconeogenesis
pathway. Fermentation product of blueberry is potential
to modify the phenolic (chlorogenic acid and gallic acid)
contents, increase antioxidant activity and increase glucose
uptake by 48% in C2C12 myotubes and by 142% in 3T3-
L1 adipocytes. In addition, rutin can improve hyperglycemia
and dyslipidemia while inhibiting the progression of liver
and heart dysfunction in STZ-induced diabetic rats.
3.4. Eﬀect of FP on Plasma Lipid Peroxidation. The increased
TBARS level may have an important role in pancreatic
damage associated with diabetes. Increasing blood glucose
levels in diabetes leads to overproduction of free radicals,
deﬁned as an imbalance between oxidants and antioxidants.
Glucose autooxidizes in the presence of transition metal
ions generating oxygen-free radicals, make the membrane
vulnerable to oxidative damage [42–44]. Natural fermented
products have been used to improve health as well as an
alternative therapy, possibly due to their antioxidative, anti-
inﬂammatory, antigenotoxic, free-radicals scavenging, and
antilipid peroxidation activities [13, 17, 18, 45–48].
Under diabetic conditions, the level of lipid peroxida-
tion in the pancreas is much higher than in nondiabetic
rats (Figure 5). During the experimental period, diabetic
rats had higher lipid peroxidation in plasma than normal
rats. Oxidative stress is associated with lipid peroxidation,
which was analyzed by measuring TBARS levels. Lipid
peroxidation is the result of a chain reaction induced by
ROS and eventually leads to extensive membrane damage,
dysfunction, and complications. Tissue and blood MDA
levels in STZ-induced diabetic rats increased because of lipid
peroxidation [49–51]. Previous studies, both in vitro and in
vivo, have shown antioxidation activity to inhibit and reduce
the degeneration of cells, through its antioxidation activity.
Studiesin Japan, Korea and Taiwan [18, 52, 53]r e p o r t e dt h a t
natural fermented product reduced lipid peroxidation.
In this study, the administration of FP at doses of 2 and
6mL/kg signiﬁcantly decreased MDA levels of diabetic rats
during the experimental period in a dose-dependentmanner
at the 6th week, when compared to the diabetic control
(P<. 05). Throughout the experiment the lipid peroxidation
marker, MDA had a tendency to decrease, exhibiting a relief
of oxidative stress. Obviously, FP containing phenolics (such
as phenols and ﬂavonoids) show promise as therapeutic
agents for such disorders involving free radical reactions as
diabetes, due to their chain-breaking antioxidants property.
3.5. Eﬀect of FP on Erythrocyte Oxidative Stress. The diabetic
rats had higher RBC oxidative stress than normal rats in the
initial period of the experiment (Figure 5). The administra-
tion of FP resulted in a decrease (85.8% and 79.7%) in the
erythrocyte ROS levelsat dosesof 2 and 6mL/kg BW daily to
diabetic rats from initiation to the 6th week compared with
diabetic rats control group (70.8%) but not signiﬁcantly.
Over the experimental period, RBC oxidative stress was
increased in diabeticrats, reﬂecting theprimary ofpathology
of diabetic complications. Interestingly, the administration
of FP for 6 weeks tended to reduce free radicals of RBC.
Based on these results we would expect FP to prevent the
development of diabetes and its complication. However, the
data from the in vivo studies of FP is still limited. Beneﬁcial
health eﬀects of phenolics depend on free-radical scavenging
activities, and also due to the inﬂuence on gene expression,
and the cell signaling cascades oxidative stress status.
3.6. Eﬀect of FP on Plasma Superoxide and Nitric Oxide
Level. As shown in Figure 5, the plasma superoxide and
nitric oxide levels ﬂuctuated during the study in all groups,
except for diabetic rats treated with low-dose FP, which the8 Evidence-Based Complementary and Alternative Medicine
0
0.5
1
1.5
2
2.5
3
3.5
4
0123456
∗
∗
Time (weeks)
P
l
a
s
m
a
T
B
A
R
S
c
o
n
c
e
n
t
r
a
t
i
o
n
(
μ
M
)
(a)
0
10
20
30
40
50
60
70
0123456
Time (weeks)
E
r
y
t
h
r
o
c
y
t
e
R
O
S
l
e
v
e
l
(
F
I
u
n
i
t
)
(b)
0
0.05
0.1
0.15
0.2
0.25
0123456
Time (weeks)
P
l
a
s
m
a
n
i
t
r
i
c
o
x
i
d
e
l
e
v
e
l
s
(
O
D
5
4
0
n
m
)
Normal
DM
DM + 2mL FP/kg/day
DM + 6mL FP/kg/day
(c)
0
0.01
0.02
0.03
0.04
Normal
DM
DM + 2mL FP/kg/day
DM + 6mL FP/kg/day
0.05
0.06
0.07
0.08
0123456
Time (weeks)
P
l
a
s
m
a
n
i
t
r
i
c
o
x
i
d
e
c
o
n
c
e
n
t
r
a
t
i
o
n
s
(
μ
M
n
i
t
r
i
t
e
e
q
u
i
v
a
l
e
n
t
)
(d)
Figure 5: Eﬀect of the FP on oxidative stress status of STZ-induced diabetic rats. Data are expressed as mean ± SEM. #P<. 05 when
compared with the normalcontrol group, ∗P<. 05 when compared with the diabetic group (DM).
levels were progressively lowered throughout the treatment,
but no signiﬁcant diﬀerences were found. Under diabetic
conditions, hyperglycemia leads to overproduction of O2
•−
and NO as a result of NAD(P)H oxidase-dependent glucose
oxidation and/or nonenzymatic protein glycation. O2
•− is
a mediator of endothelial dysfunction in diabetes whereas
NO is responsible for harmful eﬀects on β-cell function
and it interacts with O2
•− to form the hydroxyl radicals,
leading to highly reactive oxidative damage associated with
diabetes [7, 42, 54, 55]. Our results showed that rats with
STZ-induced diabetes had high plasma levels of O2
•− and
NO, implying that STZ leads to oxidative stress which will
ultimately aﬀect the β-cell function. This study showed that
FP decreased O2
•− induced by diabetes. Since the half life of
O2
•− and NO are too short to measure, the eﬀect of FP on
them are uncertain. These ﬁndings suggest that FP may act
as a free-radical scavengerand provide protection against the
oxidative stress induced by hyperglycemia.
4.Conclusions
The results of this study imply that a biologically fer-
mented product from ﬁve Thai indigenous plants including
Phyllanthus emblica, Morinda citrifolia, Houttuynia cordata,
Terminalia chebula,a n dKaempferia parviﬂora markedly
reduce the oxidative stress through scavenging free radicals
as well as inhibiting lipid peroxidation and slightly improve
glucose metabolism in STZ-induced diabetic rats. It may be
a beneﬁcial therapy or at least a delay to the pathological
conditionsassociated with oxidativestress, which leadtodia-
betic complications. On the basis of this study, these ﬁndings
have led to the discovery and the evaluation of antioxidative
property of polyphenolics: particularly rutin, gallic acid,
pyrogallol, catechin, and other phenolic compounds. Most
importantly, these compounds could synergistically inhibit,
at an early stage of cell damage, the mechanism leading
to diabetic complications. Thai indigenous plant beverage,Evidence-Based Complementary and Alternative Medicine 9
which is an already-available substance, should be used
because their eﬀective causal antioxidants. However, the use
of FP should be further investigated for correlative and
synergistic mechanisms in diabetes.
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